Patent · US Expired

Anti-atherosclerotic aryl compounds

US5658944A · kind A · utility

6Cited by
3References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 14, 1995
Grant dateAug 19, 1997
Priority date
Expiry dateApr 14, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C275/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is concerned with compounds of formula (I) ##STR1## wherein Ar is a mono- or bicyclic aromatic group optionally containing one or two heteroatoms independently selected from nitrogen, oxygen and sulphur, said group being optionally substituted by one or more atoms or groups independently selected from halogen, nitro, amino, --NRR.sup.1 where R and R.sup.1 are independently selected from hydrogen, C.sub.1-8 alkyl and C.sub.1-8 alkanoyl, cyano, carboxyalkoxy, alkoxycarbonylalkoxy, C.sub.1-8 alkyl (including cycloalkyl and cycloalkylalkyl), C.sub.1-8 alkoxy (including cycloalkoxy and cycloalkylalkoxy), C.sub.1-8 thioalkyl, said alkyl, alkoxy and/or thioalkyl group(s) being optionally substituted by one or more halogen atoms, aryl, aryloxy, aralkyl and aralkyloxy, said aryl, aryloxy, aralkyl and/or aralkyloxy group(s) being optionally substituted by one or more atoms or groups independently selected from halogen, alkyl, alkoxy, alkanoyl, hydroxyalkyl, perfluoroalkyl, perfluoroalkoxy, carboxyalkoxy, alkoxycarbonylalkoxy, and C.sub.3-8 polyether groups containing from one to three oxygen atoms; PA1 D is --CH.sub.2 --, --NH--, or --O--; PA1 E is --N< or --CH<; PA1 G …

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.